Incidence of exudative AMD and non-exudative AMD in EPO users were significantly lower than in non-EPO users (1.84 vs. 5.10 and 8.68 vs. 15.3 per 1000 person-years), respectively, the corresponding aHRs were 0.48 (95% CI = 0.40–0.61) and 0.61 (95% CI = 0.53–0.69), respectively (Table 3). The gene discussed is EPO; the disease is age-related macular degeneration.